Showing results (461-470 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|November 26, 2021
Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trialJacob D Soumerai, Anthony R Mato, Ahmet Dogan, et al.
The Lancet. Haematology|November 26, 2021
Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 studyCatherine Diefenbach, Brad S Kahl, Andrew McMillan, et al.
The Lancet. Haematology|November 26, 2021
Racial and ethnic survival disparities in patients with haematological malignancies in the USA: time to stop ignoring the numbersBhavana Bhatnagar, Ann-Kathrin Eisfeld
The Lancet. Haematology|September 2, 2022
Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendationAdam M Gwozdz, Cindy M M de Jong, Luz Sousa Fialho, et al.
The Lancet. Haematology|October 8, 2021
Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of careVanessa E Kennedy, Rebecca L Olin
The Lancet. Haematology|September 24, 2021
All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trialQiu-Sha Huang, Yi Liu, Jing-Bo Wang, et al.
The Lancet. Haematology|February 12, 2022
Risk factors associated with venous and arterial neonatal thrombosis in the intensive care unit: a multicentre case-control studyRukhmi Bhat, Soyang Kwon, Isabella Zaniletti, et al.
The Lancet. Haematology|February 3, 2022
Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trialRick Admiraal, Stefan Nierkens, Marc B Bierings, et al.
The Lancet. Haematology|March 31, 2022
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trialDavid I Marks, Amy A Kirkwood, Clare J Rowntree, et al.
The Lancet. Haematology|September 12, 2018
Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort studyKirstine Kobberøe Søgaard, Kasper Adelborg, Bianka Darvalics, et al.
Pageof 73